<p>(A) A homogeneous dose of 2.10 <i>Gy</i> for the case is delivered (Top), and a homogeneous dose of 2.23 <i>Gy</i> for is instead applied (Bottom), assuming in both cases of (A) the low migration rate and CSC cycle duration equal to 96 <i>h</i>. (B) A homogeneous dose of 2.36 <i>Gy</i> is delivered (Top) and a homogeneous dose of 2.52 <i>Gy</i> (Bottom) for the case with the high migration rate and CSC cycle durations equal to 96 <i>h</i> (Top) and 48 <i>h</i> (Bottom). In all cases (A, B) a standard scheduling (30 sessions along 6 weeks separated by 24 hours intervals except for weekends) was applied. From left to right we show in sequential order the tumor before radiotherapy treatment starts, its state after sessions 10, 20 and 30,...
Tumor regrowth and heterogeneity are important clinical parameters during radiotherapy, and the prob...
The importance of effects related to the repair of sublethal radiation damage as treatment duration ...
<p>Protocols were designed to induce a cell cycle response in the tumour which can be exploited in f...
<p>Cell growth curves are shown corresponding to homogeneous tumor growth for the low and high migra...
<p>Cell survival curves for 20 simulations (with different seeds of a random number generator) in th...
<p>(A) Various tumor cell populations as a function of time in the case of free tumor growth. A homo...
<p>Cell survival curves for 20 simulations (with different seeds of a random number generator) are s...
OBJECTIVES: Tumour re-population during radiotherapy was identified as an important reason for treat...
<p><b>A</b> Comparison of total tumour size in response to altered scheduling of the standard dose o...
<p><b>A</b> Visualisation of the radiation timing in selected fractionation schedules is provided in...
<p>In all cases, treatment sessions were scheduled along 6 weeks separated by 24 hours intervals exc...
<p>(<b>A</b>) Probability of tumor extinction with varying the time from surgery to the start of BCG...
<div><p>Tumor heterogeneity is widely considered to be a determinant factor in tumor progression and...
Tumor heterogeneity is widely considered to be a determinant factor in tumor progression and in part...
Tumor heterogeneity is widely considered to be a determinant factor in tumor progression and in part...
Tumor regrowth and heterogeneity are important clinical parameters during radiotherapy, and the prob...
The importance of effects related to the repair of sublethal radiation damage as treatment duration ...
<p>Protocols were designed to induce a cell cycle response in the tumour which can be exploited in f...
<p>Cell growth curves are shown corresponding to homogeneous tumor growth for the low and high migra...
<p>Cell survival curves for 20 simulations (with different seeds of a random number generator) in th...
<p>(A) Various tumor cell populations as a function of time in the case of free tumor growth. A homo...
<p>Cell survival curves for 20 simulations (with different seeds of a random number generator) are s...
OBJECTIVES: Tumour re-population during radiotherapy was identified as an important reason for treat...
<p><b>A</b> Comparison of total tumour size in response to altered scheduling of the standard dose o...
<p><b>A</b> Visualisation of the radiation timing in selected fractionation schedules is provided in...
<p>In all cases, treatment sessions were scheduled along 6 weeks separated by 24 hours intervals exc...
<p>(<b>A</b>) Probability of tumor extinction with varying the time from surgery to the start of BCG...
<div><p>Tumor heterogeneity is widely considered to be a determinant factor in tumor progression and...
Tumor heterogeneity is widely considered to be a determinant factor in tumor progression and in part...
Tumor heterogeneity is widely considered to be a determinant factor in tumor progression and in part...
Tumor regrowth and heterogeneity are important clinical parameters during radiotherapy, and the prob...
The importance of effects related to the repair of sublethal radiation damage as treatment duration ...
<p>Protocols were designed to induce a cell cycle response in the tumour which can be exploited in f...